WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
Summary
The FDA’s Pharmacy Compounding Advisory Committee is holding a second day meeting to discuss whether certain peptides should be more easily available. Some panel members support easing restrictions, but FDA scientists and many experts warn there is not enough evidence to prove the peptides are safe or effective.Key Facts
- The FDA committee is considering allowing wider use of several peptides, which are popular compounds promoted by wellness influencers.
- On the first day, the panel narrowly recommended easier access to these peptides.
- Government scientists warned the peptides have not been proven safe or effective.
- Health Secretary Robert F. Kennedy Jr. supports loosening the rules and opposes restrictions from President Biden’s administration.
- Influencers like Joe Rogan and Gary Brecka promote peptides for benefits such as muscle building and anti-aging.
- Some advisory panel members have financial ties to the peptide industry, including clinics and pharmacies that sell or produce peptides.
- Additional experts without industry ties were added to the panel to provide a broader perspective.
- The panel’s vote is advisory and the FDA does not have to follow its recommendations.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
